| Bioactivity | INF7 is a derivative of the N-terminal domain of the HA2 protein that can be used to enhance the endosomal escape of polyplexes or liposome-encapsulated proteins[1]. |
| Name | INF7 |
| CAS | 185462-59-3 |
| Sequence | Gly-Leu-Phe-Glu-Ala-Ile-Glu-Gly-Phe-Ile-Glu-Asn-Gly-Trp-Glu-Gly-Met-Ile-Asp-Gly-Trp-Tyr-Gly-Cys |
| Shortening | GLFEAIEGFIENGWEGMIDGWYGC |
| Formula | C124H169N27O37S2 |
| Molar Mass | 2693.96 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ayman El-Sayed, et al. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape. J Control Release. 2009 Sep 1;138(2):160-7. |
INF7
CAS: 185462-59-3 F: C124H169N27O37S2 W: 2693.96
INF7 is a derivative of the N-terminal domain of the HA2 protein that can be used to enhance the endosomal escape of pol
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.